Policy Leeds launched to link academics with policymakers
A new policy institute has launched at the University of Leeds - aimed at strengthening the ties between the University’s world-renowned research community and policymakers around the globe.
News
Leeds professor joins Digital Futures Commission
A leading academic from the University of Leeds has joined an influential panel of experts on the newly-launched Digital Futures Commission.
Breakthrough technology boosts breast cancer diagnosis
New technology which helps doctors more accurately diagnose breast cancer has been recognised by the US Food & Drugs Administration (FDA) for its exceptional potential clinical value.
Universities unite over global climate challenges
A global coalition of leading climate research universities has urged world leaders to act now to avoid catastrophic environmental consequences.
Space research aims to boost Yorkshire economy
The University is to help spearhead a national programme of technological revolution backed by the UK Space Agency.
Research collaboration with West Coast Partnership
The University has announced a research agreement with the West Coast Partnership, the franchise that runs rail services on the West Coast Main Line and selected as the operator of phase one of HS2.
Pre-surgery chemotherapy benefits to be explored
The benefits of giving chemotherapy before surgery to bowel cancer patients will be further explored in a new £3.4 million trial, one of three awarded regional funding.
Waves of praise for Lighthouse Labs scientists
University staff and students have been recognised for their role in helping to establish the Alderley Park Lighthouse Laboratory in Cheshire, a key part of the Government’s COVID-19 testing strategy.
Parasite discovery could assist mental health treatments
New research into how a common parasite infection alters human behaviour could help development of treatments for schizophrenia and other neurological disorders.
New trial for bone marrow cancer patients facing poor outcomes
A new clinical intervention trial aims to improve outcomes for patients with the bone marrow cancer multiple myeloma (MM).